Abstract:Dysregulation of the extracellular matrix (ECM) occurs widely across cardiovascular pathologies. Recent work has revealed important roles for the «a disintegrin-like and metalloprotease domain with thrombospondin-type 1 motifs like" (ADAMTSL) family of secreted glycoproteins in cardiovascular tissues during development and disease. Key insights in this regard have come from naturally occurring gene mutations in humans and animals that result in severe diseases with cardiovascular manifestations or aortopathies. Expression of ADAMTSL genes is greatly increased in the myocardium during heart failure. Genetically modified mice recapitulate phenotypes of patients with ADAMTSL mutations and demonstrate important functions in the ECM. The novel functions thus disclosed are intriguing because, while these proteins are neither structural, nor proteases like the related ADAMTS proteases, they appear to act as regulatory, i.e., matricellular proteins. Evidence from genetic variants, genetically engineered mouse mutants, and in vitro investigations have revealed regulatory functions of ADAMTSLs related to fibrillin microfibrils and growth factor signaling. Interestingly, the ability to regulate transforming growth factor (TGF)β signaling may be a shared characteristic of some ADAMTSLs. TGFβ signaling is important in cardiovascular development, health and disease and a central driver of ECM remodeling and cardiac fibrosis. New strategies to target dysregulated TGFβ signaling are warranted in aortopathies and cardiac fibrosis. With their emerging roles in cardiovascular tissues, the ADAMTSL proteins may provide causative genes, diagnostic biomarkers and novel treatment targets in cardiovascular disease. Here, we discuss the relevance of ADAMTSLs to cardiovascular medicine.

Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease

GAS6/TAM Axis as Therapeutic Target in Liver Diseases

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)

Immunological role of Gas6/TAM signaling in hemostasis and thrombosis

The Role of the TAM Family of Receptor Tyrosine Kinases in Neural Development and Disorders

Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?

Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment

TAM Receptor Inhibition–Implications for Cancer and the Immune System

TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer

Low-density Lipoprotein Receptor-Related Protein 6-Mediated Signaling Pathways and Associated Cardiovascular Diseases: Diagnostic and Therapeutic Opportunities

Molecular insights of Gas6/TAM in cancer development and therapy

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

The role of macrophage <scp>TAM</scp> receptor family in the acute‐to‐chronic progression of liver disease: from friend to foe?

Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis

Therapeutic Targeting of Pattern Recognition Receptors to Modulate Inflammation in Atherosclerosis

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease

Oncostatin M and TLR-4 Ligand Synergize to Induce MCP-1, IL-6, and VEGF in Human Aortic Adventitial Fibroblasts and Smooth Muscle Cells

[Advance of Study on Mer Function].

Signalling Pathways Regulating Galactosaminoglycan Synthesis and Structure in Vascular Smooth Muscle: Implications for Lipoprotein Binding and Atherosclerosis

Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics